Report Code : CVMI240717001 | Published Date : July 17, 2024

Market Overview

Transcatheter Aortic Valve Implantation (TAVI), also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic stenosis in patients considered to be at high or intermediate surgical risk. The procedure involves delivering a collapsible bioprosthetic valve via catheter—typically transfemorally—to replace the diseased native valve. TAVI has rapidly gained clinical acceptance due to shorter recovery times, reduced hospital stays, and expanding indications for low-risk patients. With ongoing device innovation, growing elderly populations, and favorable reimbursement pathways, the global TAVI market is poised for robust expansion.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

3.12

Includes procedure revenue, valve units, and delivery systems

2024

6.24

CAGR 14.8 % (2019–2024), driven by low-risk patient approvals and aging demographics

2031

13.12

CAGR 11.2 % (2024–2031); potential high-growth scenario: USD 15.1 billion if expanded indications cover bicuspid valves and younger populations

Adoption Outlook – More than 350,000 TAVI procedures are anticipated worldwide in 2025, increasing to over 650,000 by 2031 with improved access and expanded training.

 

Market Drivers

  • Growing elderly population – Aortic stenosis incidence increases with age; TAVI provides lower-risk options.
  • Expanding indications – TAVI is now approved for low-risk and intermediate-risk surgical candidates in the U.S., EU, and Japan.
  • Minimally invasive benefits – Faster recovery and reduced ICU stays make it appealing for both patients and hospitals.
  • Technological advances – Smaller delivery systems, repositionable valves, and improved imaging integration support outcomes.
  • Robust clinical evidence – Trials like PARTNER 3 and Evolut Low Risk reinforce safety in younger patients.

 

Market Challenges

  • High device and procedure cost limits access in LMICs and non-reimbursed markets.
  • Stroke and pacemaker dependency risk remain post-TAVI complications.
  • Training & credentialing – Steep learning curve requires dedicated heart teams and hybrid ORs.
  • Durability concerns – Valve longevity beyond 10–15 years remains under study for younger recipients.
  • Access route limitations – Vascular anatomy can restrict transfemoral access in 10–15 % of patients.

 

Competitive Landscape

Company / Organisation

2024 Share

Core Strengths

Recent Moves

Edwards Lifesciences

35 %

SAPIEN valve family; balloon-expandable platforms

FDA approval for SAPIEN X4 in low-risk cohort (Q1 2025)

Medtronic

32 %

Evolut PRO+, self-expanding valves, alternative access kits

Launched Evolut FX with improved delivery precision (Q3 2024)

Boston Scientific

12 %

LOTUS Edge repositionable valve (relaunched), customizable sizing

CE mark reinstated after redesign (Q2 2024)

Abbott

6 %

Portico valve system with FlexNav delivery

Gained FDA IDE for new Navitor Plus valve (Q4 2024)

Others (JenaValve, Meril Life, Venus Medtech)

15 %

China & India-based firms scaling access & local manufacturing

VenusP-Valve approved for pulmonic use in Europe (Q1 2025)

 

Market Segmentation

Segment

2024 Share

CAGR ’24–’31

By Valve Type

   

Balloon-Expandable Valves

49 %

10.4 %

Self-Expanding Valves

XX %

XX %

Mechanically Expandable

XX%

9.2 %

By Access Route

   

Transfemoral

XX %

XX %

Transapical & Others

XX %

7.4 %

By End User

   

Hospitals with Hybrid ORs

XX %

10.9 %

Ambulatory Cardiac Centers

27 %

XX %

Academic & Research Institutions

XX %

11.8 %

 

Regional Analysis

North America (42 %) – Mature market with Medicare coverage; over 500 TAVI centers in the U.S. alone.
Europe (XX %) – Strong public insurance support; Germany, France, and UK lead procedural volumes.
Asia-Pacific (XX %) – Fastest CAGR 14.2 %; Japan and China expand TAVI training and reimbursement.
Latin America (XX %) – Brazil and Argentina pilot public TAVI programs; private sector drives early adoption.
Middle East & Africa (XX%) – UAE and Saudi Arabia invest in TAVI-ready cardiac infrastructure.

 

Technology & Innovation

  • Next-gen repositionable valves improve placement accuracy and reduce paravalvular leak.
  • 3D navigation integration optimises catheter alignment and valve deployment.
  • Low-profile delivery systems reduce access-site trauma and expand femoral eligibility.
  • Polymer leaflet valves under study for extended durability.
    AI-assisted imaging improves preprocedural planning and valve sizing.

 

Regulatory Landscape

  • FDA approvals for low-risk patients expand indications; CE mark harmonised under MDR.
  • China NMPA and India CDSCO fast-tracking indigenous valve systems.
  • Global Valve Registry (GVR) mandates real-world data submission for long-term surveillance.
  • EACTS & ACC guidelines provide patient selection protocols across age and risk strata.

 

Recent Developments (Q4 2023–Q2 2025)

  • Edwards received FDA approval for SAPIEN X4 valve with AI sizing module (Q1 2025).
  • Medtronic launched Evolut FX in Japan and India (Q4 2024).
  • Boston Scientific resumed LOTUS Edge EU rollout after redesign (Q2 2024).
  • Abbott initiated pivotal trial for Navitor Plus valve in bicuspid anatomy (Q4 2024).
  • Venus Medtech gained CE mark for pulmonary TAVI solution (Q1 2025).

 

Strategic Outlook

Hospitals should expand hybrid OR capacity and build TAVI-specific heart teams to support case growth. Device firms must invest in next-generation, low-risk valves, regional training programs, and outpatient workflow tools. Public health agencies should update reimbursement schedules to ensure equitable access across demographics.

 

Methodology

Clearview Market Insights aggregated registry data, OEM unit sales, payer coverage maps, and 102 interviews with interventional cardiologists, CV surgeons, and payor-policy experts across 21 countries. Projections incorporate patient-risk stratification, infrastructure build-outs, and guideline changes.






Reasons To Buy

Image



Scope

Image
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Venus Medtech (Hangzhou) Inc.
  • Peijia Medical Limited
  • MicroPort Scientific Corporation
  • Bracco S.p.A.
  • LivaNova PLC (formerly Sorin Group)
  • CryoLife, Inc.
  • Direct Flow Medical, Inc.
  • Transcatheter Technologies GmbH
  • HLT, Inc.
1. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report
1.1 Study Objectives
1.2 Transcatheter Aortic Valve Implantation (TAVI) - Overview
1.3 Reason to Read This Report
1.4 Methodology and Forecast Analysis
2. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Preface
2.1 Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report – Detailed Scope and Definitions
2.1.1 By Surgery Method
2.1.2 By Valve Frame Material
2.1.3 By Valve Size
2.1.4 By Valve Leaflets Material
2.1.5 By End User
2.1.6 By Region
3. Global Transcatheter Aortic Valve Implantation (TAVI) Dynamics
3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
3.2. Restraints – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country
3.3. Opportunities – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country
3.4. Trends – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country
3.5. PEST Analysis
3.6. Porters Five Rule Analysis
3.7. Company’s Share Analysis (CSA) by Region or By Country
3.8. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report – DROTs Impact Analysis
3.9. Epideamology Data By Country Data
4.0. Clinical Trails, Pipeline and Forecast Analysis   
4. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report , Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
4.1.Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
4.2.Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%).
4.3.Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4.4.Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Transcatheter Aortic Valve Implantation (TAVI), By Surgery Method, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
5.1 Transfemoral Implantation
5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.2 Transapical Implantation
5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.3 Transaortic Implantation
5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.4 Transcaval Implantation
5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Transcatheter Aortic Valve Implantation (TAVI), By Valve Frame Material, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
6.1 Nitinol
6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.2 Stainless Steel
6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.3 Cobalt-Chromium
6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Transcatheter Aortic Valve Implantation (TAVI), Valve Size, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
7.1 14 mm to 18 mm
7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.2 18 mm to 22 mm
7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.3 22 mm to 29 mm
7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Transcatheter Aortic Valve Implantation (TAVI), Valve Leaflets Material, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
8.1 Bovine Heart Tissue
8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Cow Heart Tissue
8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.3 Other Valve Leaflets Material
8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9. Global Transcatheter Aortic Valve Implantation (TAVI), End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 Hospitals
9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9.2 Ambulatory Surgical Centers
9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9.3 Cardiac Catheterization Laboratories
9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10. Global Transcatheter Aortic Valve Implantation (TAVI) Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
10.1 North America
10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10.2 Latin America
10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10.3 Europe
10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10.4 Asia-Pacific
10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10.5 Middle East and Africa
10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
10.6 Global Transcatheter Aortic Valve Implantation (TAVI) - Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Region, 2024 - 2031
11. North America Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.1.1 Transfemoral Implantation
11.1.2 Transapical Implantation
11.1.3 Transaortic Implantation
11.1.4 Transcaval Implantation
11.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.2.1 Nitinol
11.2.2 Stainless Steel
11.2.3 Cobalt-Chromium
11.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.3.1 14 mm to 18 mm
11.3.2 18 mm to 22 mm
11.3.3 22 mm to 29 mm
11.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.4.1 Bovine Heart Tissue
11.4.2 Cow Heart Tissue
11.4.3 Other Valve Leaflets Material
11.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.5.1 Hospitals
11.5.2 Ambulatory Surgical Centers
11.5.3 Cardiac Catheterization Laboratories
11.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.6.1 USA
11.6.2 Canada
11.7 North America Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031
11.8 Regional Trends Analysis
11.9 North America Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles
11.9.1 Company 1 (USA)
11.9.2 Company 2 (Canada)
11.9.3 Company 3 (Canada)
12. Latin America Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.1.1 Transfemoral Implantation
12.1.2 Transapical Implantation
12.1.3 Transaortic Implantation
12.1.4 Transcaval Implantation
12.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.2.1 Nitinol
12.2.2 Stainless Steel
12.2.3 Cobalt-Chromium
12.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.3.1 14 mm to 18 mm
12.3.2 18 mm to 22 mm
12.3.3 22 mm to 29 mm
12.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.4.1 Bovine Heart Tissue
12.4.2 Cow Heart Tissue
12.4.3 Other Valve Leaflets Material
12.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.5.1 Hospitals
12.5.2 Ambulatory Surgical Centers
12.5.3 Cardiac Catheterization Laboratories
12.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.6.1 Brazil
12.6.2 Mexico
12.6.3 Argentina
12.6.4 Rest of Latin America
12.7 Latin America Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031
12.8 Regional Trends Analysis
12.9 Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles
12.9.1 Company 1 (Brazil)
12.9.2 Company 2 (Mexico)
12.9.3 Company 3 (Mexico)
13. Europe Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.1.1 Transfemoral Implantation
13.1.2 Transapical Implantation
13.1.3 Transaortic Implantation
13.1.4 Transcaval Implantation
13.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.2.1 Nitinol
13.2.2 Stainless Steel
13.2.3 Cobalt-Chromium
13.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.3.1 14 mm to 18 mm
13.3.2 18 mm to 22 mm
13.3.3 22 mm to 29 mm
13.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.4.1 Bovine Heart Tissue
13.4.2 Cow Heart Tissue
13.4.3 Other Valve Leaflets Material
13.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.5.1 Hospitals
13.5.2 Ambulatory Surgical Centers
13.5.3 Cardiac Catheterization Laboratories
13.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.6.1 United Kingdom
13.6.2 Germany
13.6.3 France
13.6.4 Spain
13.6.5 Italy
13.6.6 Russia
13.6.7 Rest of Europe
13.7 Europe Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031
13.8 Regional Trends Analysis
13.9 Europe Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles
13.9.1 Company 1 (United Kingdom)
13.9.2 Company 2 (Germany)
13.9.3 Company 3 (Germany)
14. Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
14.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.1.1 Transfemoral Implantation
14.1.2 Transapical Implantation
14.1.3 Transaortic Implantation
14.1.4 Transcaval Implantation
14.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.2.1 Nitinol
14.2.2 Stainless Steel
14.2.3 Cobalt-Chromium
14.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.3.1 14 mm to 18 mm
14.3.2 18 mm to 22 mm
14.3.3 22 mm to 29 mm
14.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.4.1 Bovine Heart Tissue
14.4.2 Cow Heart Tissue
14.4.3 Other Valve Leaflets Material
14.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.5.1 Hospitals
14.5.2 Ambulatory Surgical Centers
14.5.3 Cardiac Catheterization Laboratories
14.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.6.1 China
14.6.2 Japan
14.6.3 India
14.6.4 Australia & New Zealand
14.6.5 South Korea
14.6.6 Rest of Asia-Pacific
14.7 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031
14.8 Regional Trends Analysis
14.9 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles
14.9.1 Company 1 (China)
14.9.2 Company 2 (Japan)
14.9.3 Company 3 (Japan)
15. Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
15.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.1.1 Transfemoral Implantation
15.1.2 Transapical Implantation
15.1.3 Transaortic Implantation
15.1.4 Transcaval Implantation
15.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.2.1 Nitinol
15.2.2 Stainless Steel
15.2.3 Cobalt-Chromium
15.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.3.1 14 mm to 18 mm
15.3.2 18 mm to 22 mm
15.3.3 22 mm to 29 mm
15.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.4.1 Bovine Heart Tissue
15.4.2 Cow Heart Tissue
15.4.3 Other Valve Leaflets Material
15.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.5.1 Hospitals
15.5.2 Ambulatory Surgical Centers
15.5.3 Cardiac Catheterization Laboratories
15.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
15.6.1 UAE
15.6.2 Saudi Arabia
15.6.3 South Africa
15.6.4 Egypt
15.6.5 Israel
15.6.6 Egypt
15.6.7 Rest of Middle East and Africa
15.7 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031
15.8 Regional Trends Analysis
15.9 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles
15.9.1 Company 1 (UAE)
15.9.2 Company 2 (Saudi Arabia)
15.9.3 Company 3 (Saudi Arabia)
16. Competition Landscape
16.1 Strategic Dashboard of Top Market Players
16.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
16.2.1 Medtronic plc
16.2.2 Edwards Lifesciences Corporation
16.2.3 Boston Scientific Corporation
16.2.4 Abbott Laboratories
16.2.5 Meril Life Sciences Pvt. Ltd
16.2.6 JenaValve Technology Inc
16.2.8 Venus Medtech 
16.2.9 NVT AG
16.2.10 HLT
16.2.12 Transcatheter Technologies GmbH
16.2.13 JC Medical Inc.
16.2.15 Braile Biomédica
16.2.16 Xeltis
16.2.17 Colibri Heart Valve LLC
16.2.19 and Micro Interventional Devices Inc.
17. Data Collection Method and Research Approach
18. Principal Presumptions and Acronyms